What We're Reading: Page 152
Industry reads hand-picked by our editors
Aug 30, 2021
-
Reuters
Biogen offers free Alzheimer's drug as Medicare payment uncertainty remains
-
Financial Times
Pfizer ramps up its salesforce in battle of vaccine boosters
-
STAT
Four ways Elizabeth Holmes could win over a jury
-
The Wall Street Journal
Catalent to Buy Supplement Maker Bettera Holdings for $1 Billion
Aug 27, 2021
-
The Wall Street Journal
Elizabeth Holmes’s Trial Could Reveal Her Side of Theranos Story
-
Science
Having SARS-CoV-2 once confers much greater immunity than a vaccine—but no infection parties, please
-
Evaluate Vantage
ESC 2021 – Jardiance blows Entresto out of the water
-
Reuters
U.S. judge declines to stop J&J from splitting talc liabilities from main business
Aug 26, 2021
-
The Wall Street Journal
Biden Administration Likely to Approve Covid-19 Boosters at Six Months Instead of Eight
-
Bloomberg
Cassava Plunges After Alzheimer’s Data Draws Scrutiny, Shorts
-
Science
New WHO group aims to improve efforts to find pathogen origins
-
Bloomberg
Advent Said to Weigh Purchase of Swedish Biotech Firm Sobi
Aug 25, 2021
-
MIT Technology Review
Is Ginkgo’s synthetic-biology story worth $15 billion?
-
The Atlantic
The FDA Really Did Have to Take This Long
-
The Boston Globe
Moderna is now the third largest biotech employer based in Mass.
-
Endpoints News
Roche tees up $3B+ for Shape's RNA editing platform, with the bold promise of 'one-time' cures for Alzheimer's, Parkinson's
Aug 24, 2021
-
STAT
Flagship, Orbimed, ARCH top list of high-performing biotech VC firms
-
Bloomberg
Small-Cap Biotech Stocks Play Catch Up With Industry Leaders
-
Endpoints News
PDUFA VII: What's new, and what's significant in the next user fee deal
-
Fierce Biotech
Merck KGaA's $4.2B bintrafusp alfa nabs a 3rd strike. Is the GSK-partnered cancer hopeful out?
Aug 23, 2021
-
Business Insider
MIT's David Sabatini on Leave Following Sexual Harassment Investigation
-
Higher Ed Dive
Would full FDA approval of coronavirus vaccines alter colleges' fall plans?
-
The New York Times
Maker of Rapid Covid Tests Told Factory to Destroy Inventory
-
POLITICO
White House to House Dems: Drug price plan is a winning issue
Aug 20, 2021
-
Science
New SARS-CoV-2 variants have changed the pandemic. What will the virus do next?
-
Reuters
Richard Sackler says Purdue family did not contribute to opioid epidemic
-
The Washington Post
U.S. officials reviewing possibility Moderna vaccine is linked to higher risk of uncommon side effect than previously thought
Previous
